Literature DB >> 28224260

Modeling restricted mean survival time under general censoring mechanisms.

Xin Wang1, Douglas E Schaubel2.   

Abstract

Restricted mean survival time (RMST) is often of great clinical interest in practice. Several existing methods involve explicitly projecting out patient-specific survival curves using parameters estimated through Cox regression. However, it would often be preferable to directly model the restricted mean for convenience and to yield more directly interpretable covariate effects. We propose generalized estimating equation methods to model RMST as a function of baseline covariates. The proposed methods avoid potentially problematic distributional assumptions pertaining to restricted survival time. Unlike existing methods, we allow censoring to depend on both baseline and time-dependent factors. Large sample properties of the proposed estimators are derived and simulation studies are conducted to assess their finite sample performance. We apply the proposed methods to model RMST in the absence of liver transplantation among end-stage liver disease patients. This analysis requires accommodation for dependent censoring since pre-transplant mortality is dependently censored by the receipt of a liver transplant.

Entities:  

Keywords:  Dependent censoring; Generalized linear model; Inverse weighting; Pre-treatment survival; Restricted mean lifetime; Transplantation

Mesh:

Year:  2017        PMID: 28224260      PMCID: PMC5565738          DOI: 10.1007/s10985-017-9391-6

Source DB:  PubMed          Journal:  Lifetime Data Anal        ISSN: 1380-7870            Impact factor:   1.588


  20 in total

1.  Causal inference on the difference of the restricted mean lifetime between two groups.

Authors:  P Y Chen; A A Tsiatis
Journal:  Biometrics       Date:  2001-12       Impact factor: 2.571

2.  Regression models for expected length of stay.

Authors:  Mia Klinten Grand; Hein Putter
Journal:  Stat Med       Date:  2015-10-26       Impact factor: 2.373

3.  Decomposition of number of life years lost according to causes of death.

Authors:  P K Andersen
Journal:  Stat Med       Date:  2013-07-09       Impact factor: 2.373

Review 4.  Pseudo-observations in survival analysis.

Authors:  Per Kragh Andersen; Maja Pohar Perme
Journal:  Stat Methods Med Res       Date:  2009-08-04       Impact factor: 3.021

Review 5.  Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors.

Authors:  F E Harrell; K L Lee; D B Mark
Journal:  Stat Med       Date:  1996-02-28       Impact factor: 2.373

Review 6.  Comparison of stopped Cox regression with direct methods such as pseudo-values and binomial regression.

Authors:  Hans C van Houwelingen; Hein Putter
Journal:  Lifetime Data Anal       Date:  2014-08-02       Impact factor: 1.588

7.  On the C-statistics for evaluating overall adequacy of risk prediction procedures with censored survival data.

Authors:  Hajime Uno; Tianxi Cai; Michael J Pencina; Ralph B D'Agostino; L J Wei
Journal:  Stat Med       Date:  2011-01-13       Impact factor: 2.373

8.  Restricted mean models for transplant benefit and urgency.

Authors:  Fang Xiang; Susan Murray
Journal:  Stat Med       Date:  2012-01-11       Impact factor: 2.373

Review 9.  A model to predict survival in patients with end-stage liver disease.

Authors:  P S Kamath; R H Wiesner; M Malinchoc; W Kremers; T M Therneau; C L Kosberg; G D'Amico; E R Dickson; W R Kim
Journal:  Hepatology       Date:  2001-02       Impact factor: 17.425

10.  On the restricted mean survival time curve in survival analysis.

Authors:  Lihui Zhao; Brian Claggett; Lu Tian; Hajime Uno; Marc A Pfeffer; Scott D Solomon; Lorenzo Trippa; L J Wei
Journal:  Biometrics       Date:  2015-08-24       Impact factor: 2.571

View more
  11 in total

1.  Deep Neural Networks for Survival Analysis Using Pseudo Values.

Authors:  Lili Zhao; Dai Feng
Journal:  IEEE J Biomed Health Inform       Date:  2020-11-04       Impact factor: 5.772

2.  Special issue dedicated to Jack Kalbfleisch.

Authors:  Douglas E Schaubel; Bin Nan
Journal:  Lifetime Data Anal       Date:  2018-01       Impact factor: 1.588

3.  Stratified Restricted Mean Survival Time Model for Marginal Causal Effect in Observational Survival Data.

Authors:  Ai Ni; Zihan Lin; Bo Lu
Journal:  Ann Epidemiol       Date:  2021-10-04       Impact factor: 3.797

4.  Restricted mean survival time regression model with time-dependent covariates.

Authors:  Chengfeng Zhang; Baoyi Huang; Hongji Wu; Hao Yuan; Yawen Hou; Zheng Chen
Journal:  Stat Med       Date:  2022-06-23       Impact factor: 2.497

5.  Novel Risk Modeling Approach of Atrial Fibrillation With Restricted Mean Survival Times: Application in the Framingham Heart Study Community-Based Cohort.

Authors:  Laila Staerk; Sarah R Preis; Honghuang Lin; Juan P Casas; Kathryn Lunetta; Lu-Chen Weng; Christopher D Anderson; Patrick T Ellinor; Steven A Lubitz; Emelia J Benjamin; Ludovic Trinquart
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2020-03-31

6.  Computationally efficient inference for center effects based on restricted mean survival time.

Authors:  Xin Wang; Yingchao Zhong; Purna Mukhopadhyay; Douglas E Schaubel
Journal:  Stat Med       Date:  2019-09-09       Impact factor: 2.373

7.  Restricted mean survival time as a function of restriction time.

Authors:  Yingchao Zhong; Douglas E Schaubel
Journal:  Biometrics       Date:  2020-12-17       Impact factor: 2.571

8.  Estimation and modeling of the restricted mean time lost in the presence of competing risks.

Authors:  Sarah C Conner; Ludovic Trinquart
Journal:  Stat Med       Date:  2021-02-10       Impact factor: 2.373

9.  Deep Neural Networks For Predicting Restricted Mean Survival Times.

Authors:  Lili Zhao
Journal:  Bioinformatics       Date:  2021-01-05       Impact factor: 6.937

10.  The platelet to lymphocyte ratio is a potential inflammatory marker predicting the effects of adjuvant chemotherapy in patients with stage II colorectal cancer.

Authors:  Yu Fu; Xiaowan Chen; Yongxi Song; Xuanzhang Huang; Quan Chen; Xinger Lv; Peng Gao; Zhenning Wang
Journal:  BMC Cancer       Date:  2021-07-08       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.